Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

ADMA Biologics Inc

ADMA
Current price
9.51 USD -0.11 USD (-1.14%)
Last closed 9.56 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 2 204 503 552 USD
Yield for 12 month +135.40 %
1Y
3Y
5Y
10Y
15Y
ADMA
21.11.2021 - 28.11.2021

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey. Address: 465 State Route 17, Ramsey, NJ, United States, 07446

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.5 USD

P/E ratio

Dividend Yield

Current Year

+258 214 999 USD

Last Year

+154 079 692 USD

Current Quarter

+81 875 000 USD

Last Quarter

+73 903 677 USD

Current Year

+88 217 999 USD

Last Year

+35 265 157 USD

Current Quarter

+38 915 000 USD

Last Quarter

+30 898 936 USD

Key Figures ADMA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 55 470 000 USD
Operating Margin TTM 26.65 %
PE Ratio
Return On Assets TTM 8.51 %
PEG Ratio
Return On Equity TTM -2.43 %
Wall Street Target Price 10.5 USD
Revenue TTM 283 176 000 USD
Book Value 0.66 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 43.9 %
Dividend Yield
Gross Profit TTM 35 265 157 USD
Earnings per share -0.02 USD
Diluted Eps TTM -0.02 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -1.29 %

Dividend Analytics ADMA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ADMA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ADMA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 20.7469
Enterprise Value Revenue 5.6695
Price Sales TTM 5.3207
Enterprise Value EBITDA 285.9281
Price Book MRQ 10.1614

Financials ADMA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ADMA

For 52 weeks

3.06 USD 9.78 USD
50 Day MA 7.03 USD
Shares Short Prior Month 8 721 984
200 Day MA 4.97 USD
Short Ratio 2.92
Shares Short 8 442 938
Short Percent 3.75 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds


S

SX7EEX

14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics